Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2023/11/059490
CTRI/2023/11/059490
Not yet recruiting
未知

A prospective efficacy & safety study of intravenous Ferric Carboxy Maltose in breast cancer patients with iron deficiency anemia - FCM study

Emcure Pharmaceuticals Ltd0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Emcure Pharmaceuticals Ltd
Status
Not yet recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •1\. Females 18 yrs or older
  • •2\. Histologically proven diagnosis of breast cancer patients on follow\-up, rather than on ongoing chemotherapy.
  • •3\. Haemoglobin 8\-10g/dl or transferrin saturation \=20% regardless of the haemoglobin level.

Exclusion Criteria

  • •1\. Patients with other obvious known causes of anaemia like blood loss,
  • •Megaloblastic anaemia, Pernicious anaemia, and Haemolytic anaemia
  • •2\. Patients who are a known case of uncontrolled hypertension, recent acute
  • •illness, hematologic disorders, or those receiving any other experimental drug
  • •3\. Patients with a known significant dysfunction of pulmonary, cardiovascular,
  • •endocrine, neurological, gastrointestinal, or genito\-urinary systems not
  • •attributable to underlying malignancy
  • •4\. Patients who are receiving Iron supplements in oral or parenteral forms
  • •5\. Patients who are on erythropoietin stimulating agents

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
A Clinical Study to Compare Two Different Methods of Using The Drug Tranexamic Acid To Reduce Bleeding In Patients Undergoing Cardiac Valve Replacement SurgeriesHealth Condition 1: I359- Nonrheumatic aortic valve disorder, unspecifiedHealth Condition 2: I349- Nonrheumatic mitral valve disorder, unspecifiedHealth Condition 3: I369- Nonrheumatic tricuspid valve disorder, unspecifiedHealth Condition 4: I069- Rheumatic aortic valve disease, unspecifiedHealth Condition 5: I089- Rheumatic multiple valve disease,unspecified
CTRI/2019/09/021376SRM Medical College Hospital80
Completed
Phase 2
Evaluating the effects of intravenous immunoglobulin (IVIG) in COVID-19 patients
IRCT20151227025726N20Shahid Beheshti University of Medical Sciences80
Recruiting
Phase 2
Investigating the effect of the bone marrow-drived mesenchymal stem cells in MS patients under fingolimod therapy.
IRCT20191004044975N1Vice-presidency for science and technology120
Active, not recruiting
Phase 1
Study to Investigate the Efficacy and Safety of Intravenous Ferric Carboxymaltose in Pediatric Patients with Iron Deficiency Anemia
EUCTR2019-003821-70-PLAmerican Regent, Inc.10
Completed
Not Applicable
Evaluation of the therapeutic effect of intravenous flurbiprofen axetil against mesenteric traction syndrome by continuous measurement of systemic vascular resistance index using a FloTrac sensor.patients scheduled for elective open abdominal surgery
JPRN-UMIN000007802Daiyukai General Hospital Dep of Anesthesia40